NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.360
-0.170 (-6.72%)
At close: Oct 16, 2025, 4:00 PM EDT
2.300
-0.060 (-2.54%)
After-hours: Oct 16, 2025, 6:27 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.04 million as of October 16, 2025. Its market cap has increased by 9.03% in one year.
Market Cap
19.04M
Enterprise Value
21.45M
1-Year Change
9.03%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $19.04M, a decrease of -2.81%. That is a compound annual growth rate of -0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 20.41M | -39.13% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |